Acumen Pharmaceuticals (ABOS) Financials: Revenue & Earnings

ABOS price $2.36 +0.10 +4.42%

Ticker
ABOS
Price
$2.36
Change
+0.10 +4.42%
Market cap ?
$170.67M
P/E ?
-1.21
Dividend yield ?
0.00%
Beta ?
0.33
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
57
Quality
46
Growth
100

Stocklytics score rationale: value 57, quality 46, growth 100.

Financials

2019202020212022202320242025
1697000143600000000

Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease. A key focus for the company involves progressing ACU193, an investigational targeted immunotherapy drug candidate. This particular humanized monoclonal antibody is currently undergoing initial human testing in Phase I clinical…

Fair value

ABOS fair value Not meaningful. Price $2.36.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare ABOS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-03-29—-0.37——
2027-03-25—-0.32——
2026-10-26-0.35-0.39——
2026-08-11-0.45-0.36——
2026-05-12-0.33-0.40——
2026-03-26-0.41-0.50——
2025-11-12-0.44-0.63——
2025-08-12-0.68-0.54——
2025-05-13-0.48-0.56——
2025-03-27-0.62-0.47——
2024-11-12-0.50-0.36——
2024-08-13-0.34-0.28——
2024-05-14-0.25-0.23——
2024-03-26-0.29-0.29290.00K15.00M
2023-11-13-0.24-0.31——
2023-08-08-0.28-0.36——
2023-05-09-0.28-0.33——
2023-03-27-0.32-0.28——
2022-11-14-0.26-0.27——
2022-08-15-0.25-0.24——
2022-05-16-0.23-0.17——
2022-03-28-0.42-0.14——
2021-11-15-0.10-0.21——
2021-08-16-7.91-4.56——
2021-07-02-0.73———
2020-12-31-0.03—1.44M—
2020-09-30-0.09—730.00K—
2020-06-30-0.07—151.00K—
2020-03-31-0.07—226.00K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-17Porter DerrellBuy13.04K$1.0713.95K
2026-06-17Porter DerrellSell13.04K$2.3330.32K
2026-06-17Porter DerrellSell13.04K$1.0713.95K
2026-06-16Porter DerrellSell12.80K$2.3329.77K
2026-06-15Porter DerrellBuy6.46K$1.076.91K
2026-06-15Porter DerrellSell6.46K$2.3515.15K
2026-06-15Porter DerrellSell6.46K$1.076.91K
2026-06-09Fountain Nathan BSell6.40K$2.2314.27K
2026-06-03RA CAPITAL MANAGEMENT, L.P.Buy53.25K$2.29121.94K
2026-06-03RA CAPITAL MANAGEMENT, L.P.Buy35.50K——
2026-06-03Fountain Nathan BBuy35.50K——
2026-06-03Fountain Nathan BBuy53.25K$2.29121.94K
2026-06-03Drapkin Kimberlee CBuy53.25K$2.29121.94K
2026-06-03Drapkin Kimberlee CBuy35.50K——
2026-06-03Stalfort John A IIIBuy35.50K——
2026-06-03Stalfort John A IIIBuy53.25K$2.29121.94K
2026-06-03Porter DerrellBuy53.25K$2.29121.94K
2026-06-03Porter DerrellBuy35.50K——
2026-06-03Ives Jeffrey L.Buy53.25K$2.29121.94K
2026-06-03Ives Jeffrey L.Buy35.50K——
2026-06-03Golumbeski GeorgeBuy53.25K$2.29121.94K
2026-06-03Golumbeski GeorgeBuy35.50K——
2026-06-03Stoppel LauraBuy53.25K$2.29121.94K
2026-06-03Stoppel LauraBuy35.50K——
2026-03-16RA CAPITAL MANAGEMENT, L.P.Buy6.06M$3.3020.00M
2026-03-06Meisner Derek MBuy2.09K$1.853.87K
2026-03-06Meisner Derek MSell2.09K$3.266.81K
2026-03-06Meisner Derek MSell2.09K$1.853.87K
2026-02-27Meisner Derek MBuy9.41K$1.8517.40K
2026-02-27Meisner Derek MSell9.41K$3.0128.31K
2026-02-27Meisner Derek MSell9.41K$1.8517.40K
2026-01-28Meisner Derek MBuy2.67K$1.854.94K
2026-01-28Meisner Derek MSell2.67K$3.008.02K
2026-01-28Meisner Derek MSell2.67K$1.854.94K
2026-01-26Meisner Derek MBuy15.09K$1.8527.91K
2026-01-26Meisner Derek MSell15.09K$3.0045.26K
2026-01-26Meisner Derek MSell15.09K$1.8527.91K
2026-01-23Meisner Derek MSell5.63K$1.9010.72K
2026-01-22Meisner Derek MSell1.05K$1.841.94K
2026-01-22Siemers EricSell895$1.821.63K
2026-01-22Zuga MattSell1.69K$1.863.14K
2026-01-22OConnell Daniel JosephSell2.69K$1.885.07K
2026-01-22Barton RussellSell462$1.84850
2026-01-21Meisner Derek MSell2.25K$1.814.06K
2026-01-21Siemers EricSell2.33K$1.804.20K
2026-01-21Zuga MattSell2.47K$1.814.47K
2026-01-21OConnell Daniel JosephSell9.35K$1.8116.93K
2026-01-21Barton RussellSell2.31K$1.814.18K
2026-01-20OConnell Daniel JosephBuy299.80K——
2026-01-20OConnell Daniel JosephBuy450.00K$1.86837.00K
2026-01-16Zuga MattBuy99.13K——
2026-01-16Zuga MattBuy148.70K$1.89281.04K
2026-01-16Meisner Derek MBuy99.13K——
2026-01-16Meisner Derek MBuy148.70K$1.89281.04K
2026-01-16Siemers EricBuy99.13K——
2026-01-16Siemers EricBuy148.70K$1.89281.04K
2026-01-16Barton RussellBuy84.60K——
2026-01-16Barton RussellBuy126.90K$1.89239.84K
2026-01-16Schacterle AmyBuy126.90K$1.89239.84K
2026-01-16Schacterle AmyBuy84.60K——
2026-01-16Doherty James J.Buy250.30K$1.89473.07K
2026-01-16Doherty James J.Buy166.87K——
2026-01-12Meisner Derek MSell8.55K$1.7114.66K
2026-01-12OConnell Daniel JosephSell5.39K$1.739.31K
2026-01-09Meisner Derek MSell5.20K$1.769.17K
2026-01-09OConnell Daniel JosephSell12.94K$1.7622.83K
2026-01-08Zuga MattSell6.89K$1.8212.51K
2026-01-08Barton RussellSell3.53K$1.866.56K
2026-01-08Meisner Derek MSell6.82K$1.8212.38K
2026-01-08Meisner Derek MSell30.09K$1.8254.87K
2026-01-08OConnell Daniel JosephSell8.14K$1.8214.82K
2026-01-08Doherty James J.Sell6.47K$1.8211.77K
2026-01-07Doherty James J.Sell1.70K$1.993.38K
2026-01-07Schacterle AmySell1.10K$1.982.18K
2026-01-07Zuga MattSell4.11K$2.008.19K
2026-01-07Zuga MattSell1.70K$1.993.38K
2026-01-07OConnell Daniel JosephSell37.76K$1.9974.98K
2026-01-07Meisner Derek MSell1.70K$1.993.38K
2026-01-07Meisner Derek MSell10.07K$1.9920.04K
2026-01-07Barton RussellSell1.70K$1.993.38K
2026-01-06Zuga MattSell5.10K$1.9710.03K
2026-01-06Siemers EricSell6.83K$1.9713.44K
2026-01-06OConnell Daniel JosephSell5.10K$1.9710.03K
2026-01-06Meisner Derek MSell7.10K$1.9713.96K
2026-01-06Meisner Derek MSell3.80K$1.977.48K
2026-01-06Barton RussellSell3.62K$1.977.11K
2026-01-05Zuga MattSell4.00K$1.967.84K
2026-01-05Siemers EricSell4.00K$1.967.83K
2026-01-05OConnell Daniel JosephSell4.65K$1.979.16K
2026-01-05Meisner Derek MSell4.00K$1.967.84K
2026-01-05Barton RussellSell4.00K$1.967.83K
2025-11-06Golumbeski GeorgeBuy50.00K$1.9095.00K
2025-11-06Golumbeski GeorgeOther0——
2025-06-04RA CAPITAL MANAGEMENT, L.P.Buy19.50K$1.0720.86K
2025-06-04RA CAPITAL MANAGEMENT, L.P.Buy12.80K——
2025-06-04Stoppel LauraBuy19.50K$1.0720.86K
2025-06-04Stoppel LauraBuy12.80K——
2025-06-04Stalfort John A IIIBuy12.80K——
2025-06-04Stalfort John A IIIBuy19.50K$1.0720.86K
2025-06-04Fountain Nathan BBuy19.50K$1.0720.86K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 99, holders +10 vs prior quarter. Ownership 66.40%.

HolderSharesChangeChange %Value
RA CAPITAL MANAGEMENT, L.P.20.99M00.00%56.05M
SANDS CAPITAL ALTERNATIVES, LLC3.72M00.00%9.93M
BLACKROCK, INC.2.49M2.31M+1296.38%6.65M
ALYESKA INVESTMENT GROUP, L.P.2.45M00.00%6.55M
FRANKLIN TEMPLETON INC2.31M00.00%6.15M
ADAR1 CAPITAL MANAGEMENT, LLC2.11M-45.00K-2.09%5.64M
VANGUARD CAPITAL MANAGEMENT LLC1.67M165.79K+11.01%4.46M
KNOLLWOOD INVESTMENT ADVISORY, LLC1.63M00.00%4.35M
GEODE CAPITAL MANAGEMENT, LLC1.14M725.62K+174.33%3.05M
IKARIAN CAPITAL, LLC1.05M00.00%2.81M
HUDSON BAY CAPITAL MANAGEMENT LP955.00K-13.94K-1.44%2.55M
PATHSTONE HOLDINGS, LLC859.11K00.00%2.29M
RENAISSANCE TECHNOLOGIES LLC675.02K201.08K+42.43%1.80M
TWO SIGMA INVESTMENTS, LP622.88K92.07K+17.35%1.66M
STATE STREET CORP600.53K448.80K+295.79%1.60M
NORTHERN TRUST CORP360.74K285.53K+379.64%963.19K
VANGUARD PORTFOLIO MANAGEMENT LLC320.80K320.80KNew856.52K
DIMENSIONAL FUND ADVISORS LP291.56K171.80K+143.46%778.97K
VANGUARD FIDUCIARY TRUST CO291.24K92.01K+46.19%777.61K
BANK OF AMERICA CORP /DE/274.78K-45.44K-14.19%733.66K
BOOTHBAY FUND MANAGEMENT, LLC273.01K00.00%728.94K
ACADIAN ASSET MANAGEMENT LLC270.34K84.49K+45.46%718.00K
NOMURA HOLDINGS INC189.71K189.71KNew506.53K
GOLDMAN SACHS GROUP INC183.93K-22.76K-11.01%491.08K
BRIDGEWAY CAPITAL MANAGEMENT, LLC176.17K00.00%470.38K

Earnings and financials

Acumen Pharmaceuticals, Inc. (ABOS) trades at $2.36, with a market cap of $170.67M and a trailing P/E of -1.21. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2019202020212022202320242025
1697000143600000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Acumen Pharmaceuticals (ABOS) Financials: Revenue & Earnings

ABOS$2.36+0.10 +4.42%

$170.67M

Market Cap

-1.21

P/E

—

Forward P/E

68

Score

Price History